Penumbra (PEN) Interest & Investment Income (2023 - 2026)
Penumbra (PEN) posted quarterly Interest & Investment Income of $5.1 million for Q2 2026, up 14.86% year-over-year from $4.5 million in Q2 2025, and up 49.04% quarter-over-quarter from $3.5 million in Q1 2026.
Penumbra (PEN) Interest & Investment Income (2023 - 2026) Analysis & Trends
Penumbra (PEN) has reported Interest & Investment Income for 4 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | - |
| 10 | Penumbra | 12.81 Bn | 12.15 Bn | 264.94 Mn | 5.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Jun 30, 2025 | 4.48 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 3.09 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Sep 30, 2023 | 679,000.00 |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 644,000.00 |